First-line Therapy depending on Comorbidities and Patient Preference
[Speaker] Jaewon Oh/Yonsei Univ., Korea
Achieving Target Blood Pressure with Triple-combination Therapy, Dukarb Plus
[Speaker] Gyu Chul Oh/Catholic Univ., Korea